Mithridion enters first clinical trial in wake of financing, acquisition
Madison, Wis. — Mithridion has leveraged the acquisition of an Ohio biotech company to move into its first clinical trial, for a drug that might slow or stop the processes that kill brain cells in patients with Alzheimer's disease....